Tesamorelin is a synthetic form of the growth hormone-releasing factor (GHRF) which is used in the treatment of HIV-associated lipodystrophy. The drug Egrifta (Theratechnologies) is the 44 aa GHRF with the addition of a trans-3-hexenoic acid group.Human: N-(trans-3-hexenoyl)-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 or N-(trans-3-hexenoyl)-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2